Craig R. Travis, M.D., President. Dr. Travis founded Immugen Pharmaceuticals, Inc., in 1999 after realizing that an alternative approach to the treatment of HIV could exist based on targeting the immune system rather than the virus.
Thomas M. Fletcher III, Ph.D., Chief Scientific Officer
Dr. Thomas M. Fletcher III, Ph.D., is an experienced life scientist with vast experience in virology and pre-clinical drug development. His career has focused on developing assays for drug discovery. Dr. Fletcher has served as Program Leader, HTS and Assay Development, in the Department of Biochemistry and Molecular Biology, Southern Research Institute (SRI) Drug Discovery Division. He was responsible for overseeing assay development and validation of drug targets.
Harry F. McQuire, Senior Vice-President, Strategic and Corporate Development.
Harry has an extensive background in business, finance, and managment. He has been an officer in the Air Force, the president of a construction company in the Caribbean, and the founder of The Power Place which is a chain of locations selling emergency power equipment. He most recently was a partner in ABCB (American Business Consulting and Brokerage) specializing in finance, mergers and acquisitions.
